Press Releases

PTC is committed to serving the interests of all our stakeholders.
Pam & Kelsey
Living with PKU, United States

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Jul 30, 2024
PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
WARREN, N.J. , July 30, 2024 /PRNewswire/ -- PTC Therapeutics , Inc. (NASDAQ: PTCT) announced today the submission of the sepiapterin NDA to the U.S. FDA. The NDA submission is for the treatment of pediatric and adult patients with phenylketonuria (PKU), including the full spectrum of ages and
Read More
May 29, 2024
PTC Therapeutics to Participate at Upcoming Investor Conference
WARREN, N.J. , May 29, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conference: William Blair's 44th Annual Growth Stock Conference Tuesday, June 4 , at 9:00 am ET / 8:00 am CT The presentation will be
Read More
May 28, 2024
PTC Therapeutics Announces Validation of Sepiapterin European MAA
- Review of European marketing application for PKU now initiated - WARREN, N.J. , May 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the sepiapterin MAA for PKU has been validated and accepted for review by the EMA.       "The validation of the MAA is an
Read More
May 02, 2024
PTC Therapeutics to Participate at Upcoming Investor Conferences
WARREN, N.J. , May 2, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: RBC Capital Markets 2024 Global Healthcare Conference Tuesday, May 14 , at 11:00 am EDT Bank of America Securities 2024
Read More